Restoring TGF-β signaling in quiescent SCC cells by applying the DNA methylation inhibitor 5-azacytidine with the ligand of the retinoic acid receptor supported the existence of the aforementioned cells in a quiescent state, which delayed tumor relapse and metastasis development [135]. This evidence concerns the gene TGFB1 and neoplasm.